In contrast, other inhibitors related to signaling of potential targets of NEDD4L, such as BAY 61-3606 and anti–IL-17 neutralizing antibody, could not eliminate the phenotypic difference in DSS-induced colitis. This evidence concerns the gene IL17A and colitis.